维普中文期刊产品整合服务
231篇 您的检索式:作者名="Ratner R"
    题名 作者 年代 出处 被引量
1Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated patients with type 2 diabetes显示文摘Ratner R Want LL Fineman MS 2002Diabetes Technol Ther2002,4,1:1
2Liralutide versus glimepiridemonotherapy for type 2 diabetes(LEAD-3 Mono):a radomised,52-week,phase,III,double-blind,parallel-treatment trial显示文摘Garber A Henry R Ratner R 2009Lancet2009,373,9662:1
3Liraglutide versus glimepiride monotherapy for type 2 diabetes(LEAD-3 mono):randomised,52-week,phaseⅢ,double-blind,parallel-treatment trial显示文摘Garber A Henry R Ratner R 2009Lancet2009,373,9662:1
4Navigating change: Second -generation challenges of small -scale fisheries co - management in the Philippines and Vietnam显示文摘Ratner B D Oh E J V Pomeroy R S 2012Journal of Environmental Management2012,107,0:1
5Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus:a 1-year,randomized controlled trial显示文摘Ratner RE Dickey R Fineman M 2004Diabet Med2004,21,11:1
6The engineering of biomaterials exhibiting recog-nition and specificity显示文摘Ratner R D 1996J Molecular Recog1996,9,:1
7Hypertension complicating diabetic pregnancies:pathophysiology,management,and controversies显示文摘Sullivan S D Umans J G Ratner R 2011The Journal of Clinical Hypertension2011,13,4:1
8Effects of exenatide (Exendin-4) on glycemic control and weight over 30 weeks in metforrnin-treated patients with type 2 diabetes 显示文摘DEFRONZO R A RATNER R E HAN J 2005Diabetes Care2005,28,5:1
9Ethnic differences in perinatal outcome of gestational dia-betes mellitus显示文摘SILVA J K KAHOLOKULA J K RATNER R 2006Diabetes Care2006,29,9:1
10Effect of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities of type 2 diabetes mellitus显示文摘Freed MI Ratner R Marcovina SM 2002Am J Cardiol2002,90,:1
11Adjunctive therapy with pramlintide lowers HbAlc without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets 显示文摘Ratner R Whitehouse F Fineman MS 2005Exp Clin Endocrinol Diabetes2005,113,4:1
12Stock returns and trading volume,, evidence from the emerging markets of latin america and asia 显示文摘Ratner M Leal R P C 2001Journal of Emerging Markets2001,6,1:1
13Effects of exenatide(exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes显示文摘DeFronzo R A Ratner R E Han J 2005Diabetes care2005,28,5:1
14Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase HI, double-blind, parallel-treatment trial显示文摘Garber A Henry R Ratner R 2009Lancet2009,373,9662:1
15显示文摘KANIS D R LACROIX PG RATNER M A 1994J AmChemSoc1994,116,10:1
16Cardiovascular safety of exenatideBID: an integrated analysis from controlled clinical trials in participantswith type 2 diabetes显示文摘Ratner R Han J Nicewaraer D 2011Cardiovasc Diabetol2011,10,1:1
17Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells显示文摘DIMANGO E RATNER A J BRYAN R 1998Clin Inverst1998,101,:1
18Demographic and evolutionary responses to selective harvesting in populations with discrete generations 显示文摘Ratner S Lande R 2001 2001Ecology2001,82,11:1
19Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2diabetes mellitus显示文摘Freed MI Ratner R Marcovina SM 2002Am J Cardiol2002,90,3:1
20Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase Ⅲ, double-blind, paralleltreatment trial 显示文摘GARBER A HENRY R RATNER R 2009Lancet2009,373,9662:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费